Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report

BACKGROUND: Direct-Acting agents (DAAs) target and inhibit essential viral replication proteins. They have revolutionized the treatment of Hepatitis C virus (HCV) infection reaching high levels of sustained virologic response. However, the detection of basal resistance-associated substitutions (RASs...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldunate, Fabián, Echeverría, Natalia, Chiodi, Daniela, López, Pablo, Sánchez-Cicerón, Adriana, Soñora, Martín, Cristina, Juan, Moratorio, Gonzalo, Hernández, Nelia, Moreno, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077789/
https://www.ncbi.nlm.nih.gov/pubmed/33902462
http://dx.doi.org/10.1186/s12879-021-06080-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077789/
https://www.ncbi.nlm.nih.gov/pubmed/33902462
http://dx.doi.org/10.1186/s12879-021-06080-0

Ejemplares similares